We also offer complementary wellness services like medical weight loss and aesthetic treatments that many patients combine with peptide therapy for comprehensive care
Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a position statement of the Fatty Liver Research Group of the Korean Diabetes Association
It is recommended that a further dose reduction or alternative therapies be considered for patients with low or absent TPMT activity receiving AZASAN and xanthine oxidase inhibitors because both TPMT and XO inactivation pathways are affected (see CLINICAL PHARMACOLOGY, WARNINGS, PRECAUTIONS: Laboratory Tests and ADVERSE REACTIONS sections)
Menshikova EV, Ritov VB, Dube JJ, Amati F, Stefanovic-Racic M, Toledo FG, et al
Human liver single-cell and spatial transcriptomics have unveiled human cellular heterogeneity 8,9,10,11,12,13